Steatosis of indeterminate cause in a pediatric group: Is it a primary mitochondrial hepatopathy?;Esteatose de causa não determinada em grupo pediátrico: Hepatopatia mitocondrial primária?

Sao Paulo Medical Journal

Volumn 129, Issue 4, 2011, Pages 217-223

  Silva, Gustavo Henrique ^a   Hessel, Gabriel ^a   Coelho, Kunie Iabiku Rabello ^a   Escanhoela, Cecília Amélia Fazzio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anatomy; Fatty liver; Inborn errors; Infant; Liver; Metabolism; Mitochondria; Newborn

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CELL DENSITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; LIVER MITOCHONDRION; MALE; MICROSCOPY; MORPHOMETRICS; PRIMARY MITOCHONDRIAL HEPATOPATHY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 80053436475     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802011000400004     Document Type: Article

References (36)

1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-52.
2. Zafrani ES. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2004;444(1):3-12.
3. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and efect of lifestyle advice. Hepatology. 2006;44(2):458-65.
4. Da Silva GH, Coelho KI, Coelho CA, Escanhoela CA. Mitochondrial alterations in nonalcoholic fatty liver disease. Pediatric case description of three submitted sequential biopsies. J Gastrointest Liver Dis. 2009;18(2):215-9.
5. Zhou YJ, Li YY, Nie YQ, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13(47):6419-24.
6. Imhof A, Kratzer W, Boehm B, et al. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol. 2007;22(12):889-97.
7. Sagi R, Reif S, Neuman G, et al. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr. 2007;96(8):1209-13.
8. Ciba I, Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr. 2007;96(1):109-12.
9. Radetti G, Kleon W, Stuefer J, Pittschieler K. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr. 2006;95(7):833-7.
10. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J. 2005;52(5):519-24.
11. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr. 2005;41(4):426-9.
12. Fishbein M, Mogren J, Mogren C, Cox S, Jennings R. Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease. Clin Pediatr (Phila). 2005;44(2):135-41.
13. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42(3):641-9.
14. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child. 2004;89(7):648-52.
15. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30(1):48-53.
16. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002;97(9):2460-2.
17. Mandel H, Hartman C, Berkowitz D, et al. The hepatic mitochondrial DNA depletion syndrome: ultrastructural changes in liver biopsies. Hepatology. 2001;34(4 Pt 1):776-84.
18. Bioulac-Sage P, Parrot-Roulaud F, Mazat J P, et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation defciency): a light and electron microscopic study of the liver. Hepatology. 1993;18(4):839-46.
19. th ed. Boston: Butterworth-Heinemann; 1997.
20. Pérez-Carreras M, Del Hoyo P, Martín MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology. 2003;38(4):999-1007.
21. Morris AA. Mitochondrial respiratory chain disorders and the liver. Liver. 1999;19(5):357-68.
22. Hensley K, Kotake Y, Sang H, et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis. 2000;21(5):983-9.
23. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol. 1999;15(6):367-73.
24. Oleszczuk A, Spannbauer M, Tannapfel A, et al. Regenerative capacity difers between micro- and macrovesicular hepatic steatosis. Exp Toxicol Pathol. 2007;59(3-4):205-13.
25. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121(3):710-23.
26. Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705-25.
27. Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediat Gastroenterol Nut. 1999;28(1):4-16.
28. Natarajan SK, Eapen CE, Pullimood AB, Balasubramanian KA. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol. 2006;21(8):1240-9.
29. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 1995;67(1):101-54.
30. th ed. Oxford: Blackwell Science; 2002. p. 423-52.
31. Sternlieb I, Berger JE. Optical difraction studies of crystalline structures in electron micrographs. II. Crystalline inclusions in mitochondria of human hepatocytes. J Cell Biol. 1969;43(3):448-55.
32. Caldwell SH, Swerdlow RH, Khan EM, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol. 1999;31(3):430-4.
33. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183-92.
34. Le TH, Caldwell SH, Redick JA, et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology. 2004;39(5):1423-9.
35. Day C P, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114(4):842-5.
36. Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem. 2008;19(9):567-76.